This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Sabine Gack
Introduction
Sabine Gack is a notable inventor based in Plankstadt, Germany. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of preeclampsia. Her work has implications for improving maternal health and understanding related disorders.
Latest Patents
Sabine Gack holds a patent for the "Use of ADAM 12 for diagnosis and therapy of preeclampsia." This invention highlights the important role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. The patent outlines the use of these genes and their products, as well as ligands that bind to them, in the diagnosis and treatment of preeclampsia and associated syndromes. Furthermore, it discusses the potential for using additional genes and combinations thereof in diagnosing these conditions.
Career Highlights
Sabine Gack is affiliated with the Deutsches Krebsforschungszentrum, where she conducts her research. Her work has led to advancements in understanding the genetic factors involved in preeclampsia, contributing to the broader field of maternal-fetal medicine.
Collaborations
Throughout her career, Sabine has collaborated with esteemed colleagues, including Peter Angel and Marina Schorpp-Kistner. These collaborations have enriched her research and expanded the impact of her findings in the scientific community.
Conclusion
Sabine Gack's innovative work in the field of preeclampsia research exemplifies the importance of genetic studies in improving health outcomes. Her contributions continue to pave the way for advancements in medical diagnostics and therapies.